These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 18075308)

  • 1. Sensitive and quantitative detection of KRAS2 gene mutations in pancreatic duct juice differentiates patients with pancreatic cancer from chronic pancreatitis, potential for early detection.
    Shi C; Fukushima N; Abe T; Bian Y; Hua L; Wendelburg BJ; Yeo CJ; Hruban RH; Goggins MG; Eshleman JR
    Cancer Biol Ther; 2008 Mar; 7(3):353-360. PubMed ID: 18075308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential diagnosis between chronic pancreatitis and pancreatic cancer: value of the detection of KRAS2 mutations in circulating DNA.
    Maire F; Micard S; Hammel P; Voitot H; Lévy P; Cugnenc PH; Ruszniewski P; Puig PL
    Br J Cancer; 2002 Aug; 87(5):551-4. PubMed ID: 12189555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early detection of pancreatic cancer in patients with chronic pancreatitis: diagnostic utility of a K-ras point mutation in the pancreatic juice.
    Queneau PE; Adessi GL; Thibault P; Cléau D; Heyd B; Mantion G; Carayon P
    Am J Gastroenterol; 2001 Mar; 96(3):700-4. PubMed ID: 11280537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging human pancreatic cancer xenografts by targeting mutant KRAS2 mRNA with [(111)In]DOTA(n)-poly(diamidopropanoyl)(m)-KRAS2 PNA-D(Cys-Ser-Lys-Cys) nanoparticles.
    Amirkhanov NV; Zhang K; Aruva MR; Thakur ML; Wickstrom E
    Bioconjug Chem; 2010 Apr; 21(4):731-40. PubMed ID: 20232877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasensitive detection of KRAS2 mutations in bile and serum from patients with biliary tract carcinoma using LigAmp technology.
    Shi C; Chandrasekaran A; Thuluvath PJ; Karikari C; Argani P; Goggins M; Maitra A; Eshleman JR
    J Mol Diagn; 2009 Nov; 11(6):583-9. PubMed ID: 19815696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low value of detection of KRAS2 mutations in circulating DNA to differentiate chronic pancreatitis to pancreatic cancer.
    Marchese R; Muleti A; Brozzetti S; Gandini O; Brunetti E; French D
    Br J Cancer; 2004 Jun; 90(11):2243. PubMed ID: 15150585
    [No Abstract]   [Full Text] [Related]  

  • 7. KRAS2 mutations in human pancreatic acinar-ductal metaplastic lesions are limited to those with PanIN: implications for the human pancreatic cancer cell of origin.
    Shi C; Hong SM; Lim P; Kamiyama H; Khan M; Anders RA; Goggins M; Hruban RH; Eshleman JR
    Mol Cancer Res; 2009 Feb; 7(2):230-6. PubMed ID: 19208745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas.
    Urban T; Ricci S; Grange JD; Lacave R; Boudghene F; Breittmayer F; Languille O; Roland J; Bernaudin JF
    J Natl Cancer Inst; 1993 Dec; 85(24):2008-12. PubMed ID: 7902444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of c-Ki-ras gene codon 12 mutations from pancreatic duct brushings in the diagnosis of pancreatic tumours.
    Van Laethem JL; Vertongen P; Deviere J; Van Rampelbergh J; Rickaert F; Cremer M; Robberecht P
    Gut; 1995 May; 36(5):781-7. PubMed ID: 7797131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium.
    Lüttges J; Schlehe B; Menke MA; Vogel I; Henne-Bruns D; Klöppel G
    Cancer; 1999 Apr; 85(8):1703-10. PubMed ID: 10223563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of p16 and K-ras mutation in pancreatic adenocarcinoma and chronic pancreatitis differential diagnosis.
    Talar-Wojnarowska R; Gasiorowska A; Smolarz B; Romanowicz-Makowska H; Strzelczyk J; Janiak A; Kulig A; Malecka-Panas E
    J Physiol Pharmacol; 2004 Jul; 55 Suppl 2():129-38. PubMed ID: 15608367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KRAS and guanine nucleotide-binding protein mutations in pancreatic juice collected from the duodenum of patients at high risk for neoplasia undergoing endoscopic ultrasound.
    Eshleman JR; Norris AL; Sadakari Y; Debeljak M; Borges M; Harrington C; Lin E; Brant A; Barkley T; Almario JA; Topazian M; Farrell J; Syngal S; Lee JH; Yu J; Hruban RH; Kanda M; Canto MI; Goggins M
    Clin Gastroenterol Hepatol; 2015 May; 13(5):963-9.e4. PubMed ID: 25481712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mutation of the K-ras oncogene in pancreatic carcinoma, and application of its detection in pancreatic juice to diagnose pancreatic carcinoma].
    Sawabu N; Watanabe H; Yamaguchi Y; Okai T
    Nihon Rinsho; 1995 Feb; 53(2):511-7. PubMed ID: 7699881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shining the spotlight on shed KRAS in pancreatic cancer.
    Sempere LF; Korc M
    Cancer Biol Ther; 2008 Mar; 7(3):361-3. PubMed ID: 18614859
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnosis of pancreatic cancer by K-ras point mutation and cytology of pancreatic juice.
    Uehara H; Nakaizumi A; Baba M; Iishi H; Tatsuta M; Kitamura T; Ohigashi H; Ishikawa O; Takenaka A; Ishiguro S
    Am J Gastroenterol; 1996 Aug; 91(8):1616-21. PubMed ID: 8759672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.
    Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ
    Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of K-ras codon 12 point mutation in pancreatic juice in the diagnosis of carcinoma of the pancreas.
    Kimura W; Zhao B; Futakawa N; Muto T; Makuuchi M
    Hepatogastroenterology; 1999; 46(25):532-9. PubMed ID: 10228857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of K-ras point mutation at codon 12 in pancreatic diseases: a study in a Brazilian casuistic.
    Kubrusly MS; Cunha JE; Bacchella T; Abdo EE; Jukemura J; Penteado S; Morioka CY; de Souza LJ; Machado MC
    JOP; 2002 Sep; 3(5):144-51. PubMed ID: 12221329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia.
    Caldas C; Hahn SA; Hruban RH; Redston MS; Yeo CJ; Kern SE
    Cancer Res; 1994 Jul; 54(13):3568-73. PubMed ID: 8012983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma.
    Tada M; Omata M; Kawai S; Saisho H; Ohto M; Saiki RK; Sninsky JJ
    Cancer Res; 1993 Jun; 53(11):2472-4. PubMed ID: 8495407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.